Meta tags:
description=Stay updated with drug discovery trends on drugdiscoverytrends.com. Dive into pharma and biotech insights, from AI to neurological disease.;

Headings (most frequently used words):

in, and, of, on, more, drug, to, for, as, see, development, pharma, mice, vaccine, the, discovery, cancer, is, aaps, next, animal, pharmsci, 360, trial, it, borrows, covid, immune, memory, activate, cells, against, tumors, into, names, patrick, sinko, chief, science, officer, digital, pathology, act, mining, old, tissue, spare, future, studies, industry, drugmakers, 10, that, after, decades, failures, chemotherapy, linked, neuropathy, psilocybin, shows, promise, preventing, mgm, 15, 2026, cell, hidden, oncology, fda, life, how, precision, medicine, parameter, abbvie, maviret, hcv, offers, fresh, insights, scientists, search, tariffs, reach, smaller, warns, pressure, plate, spaghetti, talus, bio, boasts, 000, fold, faster, screening, by, skipping, protein, folding, alphabet, meta, now, spend, nearly, much, largest, commercial, vendor, selection, still, runs, word, mouth, harvard, mba, student, aims, change, with, rx, almanac, dea, targets, synthetic, kratom, related, products, mitragynine, pseudoindoxyl, 16, temporary, controls, schedule, today, adds, tracks, research, credibility, post, sponsored, content, genomics, proteomics, new, imaging, method, reveals, enzyme, activity, infectious, disease, medtech, 100, index, logs, than, 700, adverse, event, reports, involving, compounded, semaglutide, tirzepatide, 59, fewer, companies, cut, staff, q2, job, postings, rise, sai, sciences, bet, information, dense, scale, up, responding, clients, who, want, acceleration, ahead, digim, ceo, turning, microstructures, release, predictions, beyond, silver, bullet, why, frontier, trillion, obesity, market, columbia, cz, team, develops, 3m, model, outperforms, 100m, rivals, type, classification, spatial, biology, transforming, our, understanding, cellular, environments, biotech, 2025, smarter, investments, emphasis, rwd, clinical, trials, cured, 96, participants, real, world, complicated, greenlights, viiv, tivicay, pd, hiv, positive, newborns, first, month, measles, cases, hit, 35, year, high, trump, executive, order, backs, narrower, childhood, list, ends, wait, reality, acute, merck, moderna, customized, each, patient, tumor, chemo, overtreatment, comes, focus, atossa, bets, tamoxifen, active, form, concertai, turned, cancerlinq, point, care, intelligence, platform,

Text of the page (most frequently used words):
the (45), and (39), #pharma (25), drug (19), for (17), discovery (15), development (13), with (11), more (11), 2026 (10), aaps (9), pharmaceutical (8), that (8), 360 (8), #cancer (7), see (7), scientists (7), research (7), pharmsci (7), medical (6), how (6), chemotherapy (6), disease (5), oncology (5), biotech (5), this (5), world (5), design (5), industry (5), vaccine (5), covid (5), memory (5), mice (5), across (5), life (5), clinical (5), sponsored (5), data (5), sinko (5), index (4), immune (4), cells (4), has (4), trials (4), studies (4), when (4), have (4), activity (4), sciences (4), october (4), science (4), digital (4), subscribe (3), 2025 (3), infectious (3), about (3), our (3), companies (3), get (3), into (3), borrows (3), activate (3), against (3), tumors (3), psilocybin (3), promise (3), neuropathy (3), trial (3), linked (3), case (3), university (3), understanding (3), cell (3), next (3), enzyme (3), can (3), researchers (3), new (3), hidden (3), services (3), product (3), approaches (3), infor (3), landscape (3), insights (3), will (3), tracks (3), scientific (3), animal (3), from (3), pathology (3), tissue (3), patrick (3), chief (3), officer (3), advertise (2), 2021 (2), 2022 (2), 2023 (2), 2024 (2), pharmsci360 (2), webinars (2), views (2), podcast (2), video (2), features (2), resources (2), neurological (2), women (2), home (2), arrowfly (2), all (2), may (2), used (2), outsourcing (2), news (2), medtech (2), 100 (2), market (2), current (2), now (2), intelligence (2), comes (2), merck (2), had (2), results (2), two (2), cipn (2), patients (2), after (2), decades (2), failures (2), shows (2), preventing (2), abbvie (2), maviret (2), hcv (2), high (2), fda (2), first (2), pandemic (2), cleveland (2), based (2), use (2), preclinical (2), stage (2), therapies (2), center (2), precision (2), medicine (2), parameter (2), been (2), regions (2), imaging (2), method (2), bryce (2), rutter (2), head (2), consulting (2), changes (2), optimize (2), usability (2), process (2), key (2), study (2), complex (2), advancing (2), recent (2), rise (2), protocol (2), complexity (2), pressure (2), essential (2), many (2), protein (2), fewer (2), top (2), delivers (2), spanning (2), lifecycle (2), thousands (2), leaders (2), representing (2), large (2), small (2), offers (2), fresh (2), content (2), information (2), event (2), american (2), association (2), organization (2), act (2), mining (2), old (2), spare (2), future (2), guide (2), names (2), largest (2), mgm (2), drugmakers (2), search, copyright, llc, rights, reserved, material, site, not, reproduced, distributed, transmitted, cached, otherwise, except, prior, written, permission, advertising, privacy, policy, contact, newsletter, processing, tubing, extrusion, sourcing, medtech100, delivery, business, devicetalks, massdevice, connect, click, details, financial, calculated, using, big100, covered, summary, price, enewsletter, latest, trends, happening, expand, your, knowledge, stay, connected, concertai, turned, cancerlinq, point, care, platform, chemo, overtreatment, focus, atossa, bets, tamoxifen, active, form, moderna, customized, each, patient, tumor, magic, mushroom, compound, which, favorable, phase, depression, could, available, soon, 2027, shown, rodents, potential, preventative, induced, peripheral, disabling, pain, condition, caused, affects, receiving, 2014, review, found, measured, ends, wait, reality, acute, measles, cases, hit, year, trump, executive, order, backs, narrower, childhood, list, greenlights, viiv, tivicay, hiv, positive, newborns, month, cured, participants, real, complicated, left, most, population, wants, fight, celloram, company, focusing, autoimmune, diseases, chronic, inflammatory, metabolic, disorders, partnership, western, reserve, hospitals, published, smarter, investments, emphasis, rwd, spatial, biology, transforming, cellular, environments, columbia, team, develops, model, outperforms, 100m, rivals, type, classification, beyond, silver, bullet, why, frontier, trillion, obesity, negative, biosensors, often, unusable, because, sensors, lose, signal, detected, look, identical, illinois, chicago, solved, problem, allows, previously, activities, flipping, optical, readout, reveals, genomics, proteomics, arthritis, people, grasp, manipulate, object, reducing, leveraging, combination, devices, arthritic, hands, noble, evaluating, device, throughout, crucial, questions, conducting, global, multidisciplinary, contract, fragmentation, remains, artificial, revolutionize, interoperability, building, bridges, silos, machine, accelerating, management, inherently, fragmented, multiple, systems, such, optimizing, pipelines, driven, integration, fhir, years, marked, steady, endpoints, counterpoint, optimization, michael, irving, xylem, biopharmaceutical, manufacturing, there, zero, margin, error, protection, biopharma, integrated, bypass, technology, elevates, single, pump, kimberly, salgado, icon, plc, advancements, biologic, greatly, improved, ability, treat, over, last, what, sets, biosimilars, apart, anticipating, challenges, proteins, behave, inside, living, modern, yet, widely, particularly, plasmid, endogenous, tagging, reshaping, analysis, simplifying, workflows, individuals, pharmacy, accomplish, work, errors, automating, medication, distribution, automated, dispensing, cabinets, pharmacies, leading, brands, compared, ahead, digim, ceo, turning, microstructures, release, predictions, sai, bet, dense, scale, responding, clients, who, want, acceleration, cut, staff, job, postings, logs, than, 700, adverse, reports, involving, compounded, semaglutide, tirzepatide, arlington, virginia, nonprofit, launch, innovator, curated, its, conference, scheduled, ernest, morial, convention, orleans, louisiana, announced, explore, state, integrity, adds, credibility, post, read, articles, globe, converge, discuss, cutting, edge, technologies, sessions, posters, highlight, innovations, benefit, early, astrazeneca, mayo, clinic, are, just, some, field, went, specialist, interest, practical, necessity, during, pathologists, couldn, microscope, digitizing, slides, let, them, keep, working, remotely, since, then, developed, ways, extract, those, images, including, patterns, molecular, traditionally, brian, buntz, named, set, strategy, programming, person, platforms, direction, portfolio, peer, reviewed, journals, pharmacist, scientist, retains, his, academic, appointment, rutgers, editor, today, deep, dive, keytruda, holds, brand, slot, best, selling, pharmaceuticals, dea, targets, synthetic, kratom, related, products, mitragynine, pseudoindoxyl, temporary, controls, schedule, commercial, vendor, selection, still, runs, word, mouth, harvard, mba, student, aims, change, almanac, alphabet, meta, spend, nearly, much, plate, spaghetti, talus, bio, boasts, 000, fold, faster, screening, skipping, folding, tariffs, reach, smaller, warns,

Text of the page (random words):
drug discovery development pharma and biotech insights drug discovery and development home drug discovery and development drug discovery women in pharma and biotech oncology neurological disease infectious disease resources video features podcast views webinars pharmsci360 pharma 50 2026 pharma 50 2025 pharma 50 2024 pharma 50 2023 pharma 50 2022 pharma 50 2021 pharma 50 advertise subscribe aaps names patrick sinko chief science officer digital pathology s next act mining old tissue to spare future animal studies pharma tariffs reach smaller drugmakers as industry warns of r d pressure a plate of spaghetti talus bio boasts 5 000 fold faster drug screening by skipping protein folding alphabet and meta now spend nearly as much on r d as pharma s 10 largest drugmakers pharma commercial vendor selection still runs on word of mouth a harvard mba student aims to change that with rx almanac after decades of trial failures in chemotherapy linked neuropathy psilocybin shows promise in preventing it in mice dea targets synthetic kratom related products mitragynine pseudoindoxyl mgm 15 and mgm 16 for temporary controls in schedule i cancer vaccine borrows covid immune memory to activate t cells against tumors in mice the 50 largest pharmaceutical companies in the world 50 of the best selling pharmaceuticals pharma 50 deep dive keytruda holds the top brand slot today on drug discovery development by drug discovery editor october 13 2026 aaps names patrick sinko chief science officer the american association of pharmaceutical scientists aaps has named patrick j sinko ph d r ph as chief science officer sinko will set the organization s scientific strategy guide scientific programming across in person and digital platforms and guide the direction of aaps s portfolio of peer reviewed journals sinko a pharmacist and pharmaceutical scientist retains his academic appointment at rutgers by brian buntz october 5 2026 digital pathology s next act mining old tissue to spare future animal studies the field of digital pathology went from a specialist interest to a practical necessity during the pandemic when many pathologists couldn t get to the microscope digitizing slides let them keep working remotely since then researchers have developed ways to extract more information from those images including patterns linked to molecular changes in tissue traditionally the by sponsored content october 1 2026 aaps pharmsci 360 offers fresh insights for industry scientists aaps pharmsci 360 delivers research spanning the pharmaceutical product lifecycle thousands of scientists and leaders representing large and small pharma from across the globe converge at this science first event to discuss cutting edge approaches and technologies sessions and posters highlight recent innovations that can benefit early stage researchers rx 360 astrazeneca mayo clinic and merck are just some read all articles drug discovery and development see more 2026 pharmsci 360 adds tracks on research credibility and post animal drug development the arlington virginia based nonprofit american association of pharmaceutical scientists aaps will launch two innovator curated tracks at its 2026 pharmsci 360 conference scheduled for october 25 28 2026 at the ernest n morial convention center in new orleans louisiana the organization announced that the tracks will explore the current state of scientific research integrity in an ai fda logs more than 1 700 adverse event reports involving compounded semaglutide and tirzepatide as 59 fewer pharma companies cut staff in q2 in 2026 job postings rise 15 sai life sciences bet on information dense scale up and how it is responding to pharma clients who want acceleration ahead of pharmsci 360 digim ceo on turning hidden microstructures into drug release predictions sponsored content see more aaps pharmsci 360 offers fresh insights for industry scientists aaps pharmsci 360 delivers research spanning the pharmaceutical product lifecycle thousands of scientists and leaders representing large and small pharma top automated dispensing cabinets for pharmacies leading brands compared simplifying workflows is essential individuals in the pharmacy industry may accomplish more work with fewer errors by automating medication distribution how endogenous tagging is reshaping protein analysis understanding how proteins behave inside living cells is essential for modern drug discovery yet many widely used approaches particularly plasmid what sets oncology biosimilars apart anticipating key challenges in the development landscape by kimberly salgado icon plc advancements in biologic therapies have greatly improved our ability to treat cancer over the last advancing pressure protection in biopharma how integrated bypass technology elevates single use pump design by michael irving xylem in pharmaceutical and biopharmaceutical manufacturing there is zero margin for error when it comes to process complexity s counterpoint understanding protocol optimization in recent years the clinical research landscape has been marked by a steady rise in protocol complexity with more endpoints optimizing data pipelines in life sciences with ai driven integration and fhir sponsored by infor data management in life sciences is inherently complex data is fragmented across multiple systems such accelerating life sciences with ai this case study is sponsored by infor artificial intelligence can revolutionize clinical interoperability by building bridges across data silos machine advancing clinical trials and research this case study is sponsored by infor in the complex landscape of clinical trials and medical research data fragmentation remains multidisciplinary approaches optimize contract drug discovery 5 key questions in conducting global usability studies by dr bryce g rutter head noble consulting services evaluating device usability throughout the product development process is crucial a leveraging hf ux id services to optimize the design of combination devices for arthritic hands by dr bryce g rutter head of consulting services arthritis changes how people grasp and manipulate an object reducing the genomics proteomics see more new cell imaging method reveals hidden enzyme activity negative biosensors have often been unusable because as the sensors lose signal when activity is detected regions of high enzyme activity can look identical to regions with no activity researchers at the university of illinois chicago have solved this problem with a new cell imaging method that allows scientists to see previously hidden enzyme activities by flipping the optical readout of beyond the silver bullet why precision medicine is the next frontier for the 1 trillion obesity market columbia cz team develops 10 3m parameter model that outperforms 100m parameter rivals on cell type classification spatial biology transforming our understanding of cellular environments biotech in 2025 precision medicine smarter investments and more emphasis on rwd in clinical trials infectious disease see more cancer vaccine borrows covid immune memory to activate t cells against tumors in mice the covid 19 pandemic left most of the world s population with an immune memory for covid a cleveland based biotech wants to use that memory to fight cancer celloram a preclinical stage company focusing on therapies for cancer autoimmune diseases and chronic inflammatory and metabolic disorders in partnership with case western reserve university and university hospitals cleveland medical center published preclinical results for a abbvie s maviret cured 96 of hcv trial participants the real world is more complicated fda greenlights viiv s tivicay pd for hiv positive newborns in first month of life as measles cases hit a 35 year high trump executive order backs a narrower childhood vaccine list abbvie s maviret ends the wait and see reality for acute hcv oncology see more after decades of trial failures in chemotherapy linked neuropathy psilocybin shows promise in preventing it in mice the magic mushroom compound psilocybin which has had favorable results in two phase 3 trials of depression and could be available as soon as 2027 has shown promise in rodents as a potential preventative for chemotherapy induced peripheral neuropathy cipn a disabling pain condition caused by chemotherapy that affects about 30 to 50 of patients receiving chemotherapy a 2014 review found that 68 1 of chemotherapy patients across 31 studies had cipn when measured in cancer vaccine borrows covid immune memory to activate t cells against tumors in mice merck and moderna s cancer vaccine is customized for each patient s tumor as chemo overtreatment comes into focus atossa bets on tamoxifen s active form how concertai turned cancerlinq into a point of care oncology intelligence platform expand your knowledge and stay connected get the latest news and trends happening now in the drug discovery and development industry get the enewsletter medtech 100 index market summary current price the medtech 100 is a financial index calculated using the big100 companies covered in medical design and outsourcing click for index details connect with drug discovery development drug discovery and development massdevice devicetalks drug delivery business news medtech100 index medical design sourcing medical design outsourcing medical tubing extrusion pharmaceutical processing world r d world subscribe to our e newsletter about us contact us copyright 2026 arrowfly llc all rights reserved the material on this site may not be reproduced distributed transmitted cached or otherwise used except with the prior written permission of arrowfly privacy policy advertising about us search drug discovery development home drug discovery and development drug discovery women in pharma and biotech oncology neurological disease infectious disease resources video features podcast views webinars pharmsci360 pharma 50 2026 pharma 50 2025 pharma 50 2024 pharma 50 2023 pharma 50 2022 pharma 50 2021 pharma 50 advertise subscribe